Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00378 is a member of the long intergenic non-coding RNA (lincRNA) class, a group of transcripts longer than 200 nucleotides that do not overlap any annotated protein-coding genes and are not translated into proteins[1][3][5]. LincRNAs can have diverse and context-dependent biological functions, such as regulating gene expression, modulating chromatin structure, stabilizing RNAs, and participating in enhancer-associated activity[3][5]. The canonical role of lincRNAs is *not* as druggable targets in the same way as receptors, enzymes, or ion channels, but interest in their regulatory involvement in disease processes—primarily cancer—is growing[1][3][5]. There are no established therapies, biomarkers, or safety considerations associated with LINC00378 at present[1]. Information on its precise function is limited relative to better-characterized lincRNAs, such as XIST or HOTAIR, although general lincRNA mechanisms and classifications apply[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 378 (LINC00378).